Torrent J, Izquierdo I, Barbanoj M J, Moreno J, Lauroba J, Jané F
Clinical Pharmacology Research Unit, Hospital Sant Pau, Autonomous University of Barcelona, Spain.
Methods Find Exp Clin Pharmacol. 1988 May;10(5):341-5.
UV-induced erythema is a well known inflammatory model applied both in animal and human skin to test the activity of topical non-steroidal anti-inflammatory compounds in a great variety of pharmaceutical formulations. The aim of this study was to evaluate the inhibitory efficacy of piroxicam in two different topical formulations (cream 0.5, 1 and 1.5% and gel 1%) as compared to three non-steroidal compounds, benzydamine, etofenamate and indomethacin (cream 5%), on erythema induced after UV-injury on the back of 5 healthy subjects. The results showed that piroxicam in cream formulation, indomethacin cream and etofenamate gel have a similar effect, decreasing the erythema size 7 h after irradiation. However, benzydamine cream and piroxicam gel showed no effect with this method. We may conclude that this model is adequate and precise for selecting the most appropriate galenic dosage form for an active compound in terms of its clinical efficacy when topically administered.
紫外线诱导的红斑是一种广为人知的炎症模型,用于动物和人类皮肤,以测试各种药物制剂中局部非甾体抗炎化合物的活性。本研究的目的是评估吡罗昔康在两种不同局部制剂(0.5%、1%和1.5%乳膏以及1%凝胶)中的抑制效果,并与三种非甾体化合物(5%乳膏的苄达明、依托芬那酯和吲哚美辛)进行比较,观察其对5名健康受试者背部紫外线损伤后诱导的红斑的影响。结果表明,乳膏制剂中的吡罗昔康、吲哚美辛乳膏和依托芬那酯凝胶具有相似的效果,在照射后7小时可减小红斑大小。然而,苄达明乳膏和吡罗昔康凝胶用这种方法没有效果。我们可以得出结论,就局部给药时活性化合物的临床疗效而言,该模型对于选择最合适的剂型是充分且精确的。